Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry Jens Garbade, MD, PhD, Finn Gustafsson,

Slides:

Advertisements

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Advertisements

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Reply The Annals of Thoracic Surgery

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Outcomes of Reintervention on the Autograft After Ross Procedure

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Pump Replacement for Left Ventricular Assist Device Failure Can Be Done Safely and Is Associated With Low Mortality Nader Moazami, MD, Carmelo A. Milano,

Laura Harvey, MD, Christopher Holley, MD, Samit S

Jan D. Schmitto, MD, PhD, Jasmin S

Minimally Invasive Versus Sternotomy Approach for Mitral Valve Surgery in Patients Greater Than 70 Years Old: A Propensity-Matched Comparison David M.

Improved Mitral Valve Performance After Transapical Aortic Valve Implantation Martin Haensig, MD, David Michael Holzhey, MD, PhD, Michael Andrew Borger,

Dhaval Chauhan, MD, Alexis K

Bi-Ventricular Circulatory Support With the Abiomed AB5000 System in a Patient With Idiopathic Refractory Ventricular Fibrillation Li Zhang, MD, MS,

De Novo Aortic Regurgitation After Continuous-Flow Left Ventricular Assist Device Implantation Hrvoje Gasparovic, MD, PhD, Tomislav Kopjar, MD, PhD,

Sharven Taghavi, MD, MPH, Charisse Ward, MD, Senthil N

The Impact of Vacuum-Assisted Closure on Long-Term Survival After Post-Sternotomy Mediastinitis Johan Sjögren, MD, PhD, Johan Nilsson, MD, Ronny Gustafsson,

Clinical Outcome After Poststernotomy Mediastinitis: Vacuum-Assisted Closure Versus Conventional Treatment Johan Sjögren, MD, Ronny Gustafsson, MD, PhD,

Javed Butler, MD, Carrie Geisberg, MD, Renee Howser, MSN, Peer M

Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D

Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study Ivan Netuka, MD, PhD, Pierre-Yves Litzler,

Long-Term Outcomes of the Mosaic Bioprosthesis

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E

Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa.

Use of Amiodarone After Major Lung Resection

Transcatheter Aortic Valve Replacement Outcomes in Nonagenarians Stratified by Transfemoral and Transapical Approach Christian McNeely, MD, Alan Zajarias,

Left Ventricular Assist Device Inflow Angle and Pump Positional Change Over Time Adverse Impact on Left Ventricular Assist Device Function Toshinobu.

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Zain Khalpey, MD, PhD, Wernard Borstlap, Patrick O. Myers, MD, Jan D

Nicholas A. Haglund, MD, Mary E. Davis, MS, CCRP, Nicole M

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

Hybrid Management of a Giant Left Main Coronary Artery Aneurysm

William L. Holman, MD, James K. Kirklin, MD, David C

John F. Lazar, MD, Michael F. Swartz, PhD, Matthew P

Redo Aortic Valve Replacement in Children

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Erik N. Sorensen, PhD, Richard N. Pierson, MD, Erika D

Editorial Board, January 2010

Initial Clinical Experience With the HeartWare Left Ventricular Assist System: A Single- Center Report Angelo Maria Dell'Aquila, MD, Stefan Rudolf Bertram.

Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device Palak Shah, MD, MS, Francis D. Pagani, MD, PhD,

Mechanical Circulatory Support and Heart Transplantation: Donor and Recipient Factors Influencing Graft Survival Simon Maltais, MD, PhD, Nikhil P. Jaik,

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Off-Pump Plication of Left Ventricular Aneurysm

Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD

Sander Bramer, MD, Albert H. M. van Straten, MD, PhD, Mohamed A

Cost-Effectiveness of Mitral Valve Repair Versus Replacement by Biologic or Mechanical Prosthesis Ariel Beresniak, MD, PhD, Brigitte Sabatier, PharmD,

Defining Patient-Prosthesis Mismatch and Its Effect on Survival in Patients With Impaired Ejection Fraction David A. Cotoni, DO, Robert T. Palac, MD,

Invited Commentary The Annals of Thoracic Surgery

Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ranjit.

On-Pump Versus Off-Pump Surgical Revascularization for Left Main Stem Stenosis: Risk Adjusted Outcomes John C.Y. Lu, Antony D. Grayson, BS, D. Mark Pullan

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Comparing Aortic Root Replacements: Porcine Bioroots Versus Pericardial Versus Mechanical Composite Roots: Hemodynamic and Ventricular Remodeling at Greater.

Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era Veli K. Topkara, MD, Sreekanth.

Y. Joseph Woo, MD, Michael A. Acker, MD The Annals of Thoracic Surgery

Influence of Prosthesis–Patient Mismatch on Diastolic Heart Failure After Aortic Valve Replacement Shahab Nozohoor, MD, Johan Nilsson, MD, PhD, Carsten.

Costs Associated With Ventricular Assist Device Use in Children

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

The Impact of New Technology on Cardiothoracic Surgical Practice

Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement Heinrich Koertke, MD,

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Risk of Valve-Related Events After Aortic Valve Repair

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Early and Late Outcomes of Aortic Valve Replacement in Dialysis Patients Keisuke Tanaka, MD, Kazuyoshi Tajima, MD, Yoshiyuki Takami, MD, Noritaka Okada,

Repair of Left Ventricular Inflow Tract Lesions in Shone's Anomaly: Valve Growth and Long-Term Outcome Eva Maria B. Delmo Walter, MD, PhD, Richard Van.

Body Mass Index and Outcome After Ventricular Assist Device Placement

Presentation transcript:

Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry Jens Garbade, MD, PhD, Finn Gustafsson, MD, PhD, Steven Shaw, MD, PhD, Jacob Lavee, MD, Diyar Saeed, MD, PhD, Yuriy Pya, MD, Thomas Krabatsch, MD, PhD, Jan D. Schmitto, MD, PhD, Michiel Morshuis, MD, Joyce Chuang, PhD, Daniel Zimpfer, MD, PhD The Annals of Thoracic Surgery Volume 107, Issue 1, Pages 33-39 (January 2019) DOI: 10.1016/j.athoracsur.2018.07.092 Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Breakdown of groups for analysis of the ELEVATE registry. (ELEVATE = Evaluating the HeartMate 3 with Full MagLev Technology in a Post-Market Approval Setting; HM3 = HeartMate 3; LVAD = left ventricular assist device.) The Annals of Thoracic Surgery 2019 107, 33-39DOI: (10.1016/j.athoracsur.2018.07.092) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 (A) Thirty-day survival of all ELEVATE registry patients including 58 anonymized patients and 19 patients receiving the HeartMate 3 (Abbott, Chicago, IL) as a replacement for another pump. (B) Thirty-day survival of the ELEVATE registry primary implant and European Conformity Mark (CE Mark [CEM]) groups. The hazard ratio (HR) for ELEVATE registry versus CE Mark trial is adjusted for baseline differences in age, INTERMACS profile, low hematocrit, and concomitant valve procedures. (ELEVATE = Evaluating the HeartMate 3 with Full MagLev Technology in a Post-Market Approval Setting; INTERMACS = Interagency Registry for Mechanically Assisted Circulatory Support.) The Annals of Thoracic Surgery 2019 107, 33-39DOI: (10.1016/j.athoracsur.2018.07.092) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions